Table 1.

Demographic and microbiologic data of the cohort according to final outcome. Data are presented as a mean (SD) or median (IQR) for continuous measures as appropriate and n (%) for categorical measures. Others *: S. agalactiae (1); Candida albicans (1); K. aerogenes (1); E. fergusonii (1).

	Total	No Urinary Abnormalities	Urinary Abnormalities	p-Value
	N = 161	N = 115	N = 46
Female sex	68 (42%)	52 (45%)	16 (35%)	0.23
Age (months)	3 (1–8)	3 (1–6)	4 (1–48)	0.061
Urine culture Bacteria				0.23
E. coli	124 (77%)	90 (78%)	34 (74%)
K. oxytoca	3 (2%)	3 (3%)	0 (0%)
K. pneumoniae	7 (4%)	4 (3%)	3 (7%)
S. aureus	1 (1%)	1 (1%)	0 (0%)
E. faecalis	8 (5%)	7 (6%)	1 (2%)
P. aeruginosa	6 (4%)	2 (2%)	4 (9%)
P. mirabilis	3 (2%)	2 (2%)	1 (2%)
Citrobacter	3 (2%)	3 (3%)	0 (0%)
E. faecium	1 (1%)	1 (1%)	0 (0%)
Others *	5 (3%)	2 (2%)	3 (7%)
Second Germ in Urine Culture	34 (23%)	29 (28%)	5 (11%)	0.023
Blood Culture Positive	19 (12%)	7 (6%)	12 (26%)	<0.001
Same Germ in blood and urine	10 (6%)	2 (2%)	8 (17%)	<0.001
CRP	46 (14–95)	38 (10–95)	55 (28–99)	0.17
PCT	1 (0–3)	0 (0–1)	2 (1–6)	0.002